News & Events
Stay update
Capital: Cure geniali dai geni ▾
Capital: Cure geniali dai geni
Alessandra Gerli intervista Riccardo Palmisano e Claudio Bordignon
molmed_20181201_capital.pdf893.55 KBAlessandra Gerli intervista Riccardo Palmisano e Claudio Bordignon
molmed_20181201_capital.pdf893.55 KBDear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.